Dr. Reddy’s Expands Hospital Generics Business in EuropeBy
Dr. Reddy’s Laboratories has expanded its commercial operations in Europe with the introduction of its generic drug portfolio in France, where the company plans to make its generic products available to the hospital market in March 2017. The company will supply generic oncology drugs and anti-infectives, including antimycotics, to hospitals in France.
Dr. Reddy’s recently launched select products of its hospital portfolio in Italy and Spain, and is looking to further strengthen its presence in the two countries with the launch of anti-HIV products this year.
The company has a diversified portfolio of injectables and complex generics and has two research and development centers, one manufacturing facility, and a packaging and storage facility in Europe.
Source: Dr. Reddy’s Laboratories